Difference between revisions of "Fibroblastic/myofibroblastic tumours"
Jump to navigation
Jump to search
m (→Microscopic) |
|||
| Line 264: | Line 264: | ||
Notes: | Notes: | ||
*Few/absent mitoses. | *Few/absent mitoses. | ||
===IHC=== | |||
Features:<ref name=Ref_WMSP611>{{Ref WMSP|611}}</ref> | |||
*EMA +ve. | |||
*CD99 +ve. | |||
*BCL2 +ve. | |||
Others:<ref name=Ref_WMSP611>{{Ref WMSP|611}}</ref> | |||
*SMA -ve. | |||
*S100 -ve. | |||
*Desmin -ve. | |||
===Molecular pathology=== | ===Molecular pathology=== | ||
*t(7;16)(q33;p11).<ref>{{cite journal |author=Panagopoulos I, Storlazzi CT, Fletcher CD, ''et al.'' |title=The chimeric FUS/CREB3l2 gene is specific for low-grade fibromyxoid sarcoma |journal=Genes Chromosomes Cancer |volume=40 |issue=3 |pages=218–28 |year=2004 |month=July |pmid=15139001 |doi=10.1002/gcc.20037 |url=}}</ref> | *t(7;16)(q33;p11).<ref>{{cite journal |author=Panagopoulos I, Storlazzi CT, Fletcher CD, ''et al.'' |title=The chimeric FUS/CREB3l2 gene is specific for low-grade fibromyxoid sarcoma |journal=Genes Chromosomes Cancer |volume=40 |issue=3 |pages=218–28 |year=2004 |month=July |pmid=15139001 |doi=10.1002/gcc.20037 |url=}}</ref> | ||
*t(11;16).<ref name=Ref_WMSP611>{{Ref WMSP|611}}</ref> | |||
==Calcifying fibrous tumour== | ==Calcifying fibrous tumour== | ||